Stay updated on Pembrolizumab in Lymphoma Subtypes Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Lymphoma Subtypes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Lymphoma Subtypes Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Difference
    0.2%
    Check dated 2025-05-07T20:25:33.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.3%
    Check dated 2025-04-30T18:02:49.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Difference
    0.4%
    Check dated 2025-04-23T15:38:28.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The webpage has been updated to include new information about the study on pembrolizumab for treating various types of aggressive B-cell lymphomas, specifically highlighting the inclusion of gray-zone lymphoma and primary central nervous system lymphoma. Additionally, the revision number has changed from v2.14.4 to v2.15.0.
    Difference
    47%
    Check dated 2025-04-16T12:48:35.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.0%
    Check dated 2025-04-09T05:28:23.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.0%
    Check dated 2025-04-01T22:38:43.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Lymphoma Subtypes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Lymphoma Subtypes Clinical Trial page.